Monthly Archives: November 2010
Our statement on MEDCAC
RE: Statement on Centers for Medicare and Medicaid Service Development and Coverage Advisory Committee (MEDCAC) on Provenge Washington D.C. – November 17, 2010. The Ovarian Cancer National Alliance, the advocacy arm of the ovarian cancer community, works on behalf of … Continue reading
Posted in News Leave a comment
With Gratitude
A message to the ovarian cancer community from Board President Annette Leal Mattern As I reflect back on this year and the achievements of our community, every scene has been shaped by volunteer survivors and supporters. We have pulled together … Continue reading
Posted in Blog Leave a comment
Virginia Parmer – Saraland, AL
My sister Virginia was only 41 years old when she had what we thought was a bad stomach virus. After short period of time we took her to the hospital. That is when ovarian cancer came into the picture. She … Continue reading
Posted in Personal stories Leave a comment
Dianne Blankenstein’s Letter to the Editor regarding Avastin
Congresswoman Kay Granger (left) and Dianne Blankenstein (right) Protecting women’s health Sunday, November 21, 2010 I am proud of the fact that my representative, Kay Granger, felt so strongly about the issue concerning women with breast cancer and the drug … Continue reading
Posted in News Leave a comment
Wide Genetic Testing for Lynch Syndrome Cost Effective
Widespread genetic testing for Lynch Syndrome appears to be a cost-effective strategy for identifying those at risk for colorectal and endometrial cancer, according to a report in Cancer Prevention Research, a journal of the American Association for Cancer Research. “Genetic … Continue reading
Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer
Immunovaccine Inc. today announced that it will focus the Phase I/II clinical development plan for DPX-Survivac on ovarian cancer. The development plan was based on positive input from key opinion leaders in cancer immunotherapy. The Company has also successfully manufactured … Continue reading
FDA approves Xgeva to help prevent cancer-related bone injury
The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring … Continue reading
Study examines end-of-life care for cancer patients
Many in their final days receive costly, aggressive treatments they may not want, according to researchers at the Dartmouth Atlas of Health Care. In California, Los Angeles County had the highest percentage of patients dying in hospitals. One in three … Continue reading
Posted in News Tagged chemotherapy, cost of care, outcomes, quality of life, support, treatment Leave a comment
J. Crew and OCNA invite you to a Private Shopping event
J. Crew invites supporters of the Ovarian Cancer National Alliance to an evening of private shopping! WHEN: Thursday, December 9, 2010 TIME: 6:00pm-9:00pm LOCATION: J. Crew Fair Oaks Mall 11831 Fair Oaks Shopping Center Fairfax, VA Guests will receive an … Continue reading
Posted in Blog Leave a comment
J Crew Private Shopping Event
Thursday, December 9, 6 – 9pm Fair Oaks Mall, 11831 Fair Oaks Shopping Center, Fairfax, VA Join us for an evening of shopping, food and drinks at J.Crew while supporting the cause. Guests will receive 15% discount on all purchases … Continue reading
Posted in Events Leave a comment
